Form 4: HealthEquity Executive Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


HealthEquity's EVP, Chief Technology Officer, Elimelech Rosner, sold 1,707 shares of common stock to cover tax obligations.

Summary

  • Elimelech Rosner, the EVP and Chief Technology Officer of HealthEquity, Inc., sold 1,707 shares of common stock on January 7, 2025.
  • The sale was executed at a price of $97.5445 per share.
  • This transaction was done to cover tax obligations related to vesting of shares.
  • Following the transaction, Mr. Rosner directly owns 55,488 shares of HealthEquity stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, which is neither positive nor negative for the company's overall outlook.

Industry Context

This is a routine transaction for executives to manage their tax obligations related to stock-based compensation. It is common for executives to sell shares after vesting to cover taxes.

Comparison to Industry Standards

  • Executive stock sales for tax purposes are a common practice across publicly traded companies.
  • The sale by Mr. Rosner is consistent with typical insider transactions related to equity compensation.

Stakeholder Impact

  • The transaction has a minimal impact on shareholders as it is a routine sale by an executive for tax purposes.

Key Dates

DateDescription
07/07/2023Date of Power of Attorney filing by Mr. Rosner with the SEC.
01/07/2025Date of the stock sale transaction.
01/09/2025Date of the Form 4 filing.

Keywords

HealthEquity, stock sale, insider trading, executive, share transaction, tax obligations, Elimelech Rosner, HQY

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.